Roberts William T. 4
4 · RHYTHM PHARMACEUTICALS, INC. · Filed Feb 13, 2023
Insider Transaction Report
Form 4
Roberts William T.
Chief Accounting Officer
Transactions
- Exercise/Conversion
Common Stock
2023-02-09+2,313→ 7,253 total - Exercise/Conversion
Restricted Stock Units
2023-02-09−2,313→ 6,937 total→ Common Stock (2,313 underlying) - Sale
Common Stock
2023-02-09$27.66/sh−959$26,526→ 6,294 total
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
- [F2]Includes 3,463 shares acquired under Issuer's Employee Stock Purchase Plan on February 28, 2022 and August 31, 2022.
- [F3]The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported Restricted Share Units.
- [F4]The restricted stock units vest or have vested as to 25% of the total shares on each of February 9, 2023, February 9, 2024, February 9, 2025 and February 9, 2026. The restricted stock units have no expiration date.